Evidence map›Paper›PMID 8065302›Full record

ArticleMolecular and cellular biology1994

Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor.

M Reick, R W Robertson, D S Pasco, J B Fagan

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M ReickMolecular Biology Laboratory, Maharishi International University, Fairfield, Iowa 52557-1078, USA.
R W Robertson
D S Pasco
J B Fagan
Maharishi International University · US

Funding

CARCINOGEN METABOLIZING P-450S-GENE REGULATIONK04CA001557 · NCI · MAHARISHI UNIVERSITY OF MANAGEMENT · PI FAGAN, JOHN B · 1991 to 1994
–
CYTOCHROME P450 GENE STRUCTURE AND REGULATIONR01CA038655 · NCI · MAHARISHI UNIVERSITY OF MANAGEMENT · PI FAGAN, JOHN B · 1986 to 1994
–
NCI NIH HHS KO4-CA01557NCI NIH HHS R01-CA38655
6 · The paper itself

Abstract

Aryl hydrocarbons (AHs) such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and benzo[a]pyrene activate the sequence-specific DNA-binding activity of the AH receptor. In the rat hepatocyte-derived cell line LCS7, DNA-binding activity peaked after 30 min and was then down-regulated, reaching negligible levels by 2 h. Down-regulation could be blocked, and DNA-binding activity maintained at maximum for many hours by inhibiting protein or RNA synthesis, implying that down-regulation is a mediated process requiring a labile or inducible protein. CYP1A1 transcription and in vivo DNA-protein interactions at xenobiotic response elements were down-regulated in parallel with DNA-binding activity in nuclear extracts, and these changes could also be blocked by inhibitors of protein synthesis. The correlation between AH receptor DNA-binding activity, intensity of in vivo footprints at xenobiotic response elements, and CYP1A1 transcription rate implies that down-regulation of AH receptor DNA-binding activity is important in regulating CYP1A1 transcription and that receptor is required continuously to maintain transcription. This correlation extends to the murine hepatoma cell line Hepa-1c1c7, in which slower kinetics of activation and down-regulation of CYP1A1 transcription paralleled slower activation and down-regulation of AH receptor DNA-binding activity. The difference in kinetics between cell lines also implies that AH receptor DNA-binding activity is modulated by a mechanism that may be influenced by cell-specific regulatory pathways. The above observations in conjunction with mixing experiments and comparisons of cytoplasmic and nuclear extracts indicate that down-regulation of AH receptor DNA-binding activity is probably due either to degradation or to conversion of the receptor to form that is inactive in both DNA binding and transactivation.

Indexed as

Transcriptional ActivationAnimalsBase SequenceBinding SitesCell LineCell NucleusDNA-Binding ProteinsDown-RegulationGene Expression Regulation, EnzymologicIn Vitro TechniquesMiceMolecular Sequence DataNuclear ProteinsOligodeoxyribonucleotidesRatsReceptors, Aryl HydrocarbonDNA-Binding ProteinsNuclear ProteinsOligodeoxyribonucleotidesReceptors, Aryl Hydrocarbon

Identifiers

PMID8065302
PMCPMC359090
OpenAlexW2077890147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.